• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

Chemopreventive action to gastric cancer by selective cox-2 inhibitor coutribution of cox-1 inhibitor

Research Project

Project/Area Number 14570519
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionNippon Medical School

Principal Investigator

MIYAKE Kazumasa  Nippon Medical School, MD, Assistant professor, 医学部, 講師 (60247012)

Co-Investigator(Kenkyū-buntansha) SAKAMOTO Choitsu  Nippon Medical School, MD, professor, 医学部, 教授 (30196092)
Project Period (FY) 2002 – 2003
KeywordsHelicobacter pylori / Gastric adenoma / eradication / cyclooxygenase / NSAID / VEGF / IL8 / chemoprevention
Research Abstract

It is speculated that gastric cancer, especially intestinal type, cancerates through atrophic gastritis, intestinal metaplasia, or adenoma by continuation of the chronic activity gastritis by H.pylori (HP) infection. In addition, a possibility that COX-2 is involving in the tumorigenesis process is high also in the stomach, as in the colon. Then, using i) the gastric adenoma patient with HP Infection and ii) gastric epithelium cell line (MKN28) co-cultured HP infection, we investigated the influence which HP infection has on proliferation and carcinogenesis of gastric epithelium through COX. Furthermore, it aimed at exploring the possibility as chemoprevention of the gastric cancer by HP eradication treatment or NSMDs. The eradication treatment was performed to gastric adenoma patients infected with HP. 12 of 13 cases succeeded in eradication. It observes for an average of 13.1 months after eradication. In five of 12 cases (41.7%), size of the adenoma reduced, although the histological … More grade of atypia did not change. In immunohistochemistry of COX-2, the positive cells were seen focusing on the intestinal cells near the surface mucosa before eradication, and disappeared mostly after eradication. Although the positive cells of MMP-7 were seen focusing on epithelial cells of the adenoma before eradication, it decreased after eradication. Ki67 Labeling index which estimates the proliferation decreased after eradication compared with that before eradication. In MKN28, COX-2 protein was induced by HP infection (Western blot). When MKN28 was co-cultured with HP infection, IL-8 and VEGF in culture medium increased in a time-dependent manner. Furthermore, the increase was suppressed by the selective COX-1 inhibitor (SC560), the selective COX-2 inhibitor (celecoxib), or the non-selective COX inhibitor (indomethacin), respectively. HP eradication may inhibit COX-2 and MMP7 expression and VEGF and IL-8 production which have actions of proliferation and carcinogenesis. On the other hand, NSAIDs may suppress VEGF and IL-8 production who were stimulated with HP infection, through not only COX-2 but COX-1 inhibition. Eradication treatment and NSAIDs suppress carcinogenesis and proliferation of gastric epithelium, and the chemopreventive action to gastric cancer is expected. Less

  • Research Products

    (15 results)

All Other

All Publications (15 results)

  • [Publications] Miyake K, Tsukui T et al.: "Teprenone, but not H_2-receptor blocker or sucralfate, suppresses corpus H.pylori colonization and gastritis in Humans : teprenone inhibition of H.pylori-induced interleukin-8 in MKN28 gastric epithelial cell lines"Helicobacter. 9(1)(in press). (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Futagami S, Miyake K et al.: "Monocyte chemoattractant protein 1 (MCP-1) released from Helicobacter pylori stimulated gastric epithelial cells induced cyclooxygenase 2 expression and activation in T cells."Gut. 52(9). 1257-1264 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takeyama H, Miyake K et al.: "NSAIDs are not involved in ICAM-1 expression of endothelial cells but in that of gastric fibroblasts in vitro."J Tokyo Med University. 61(2). 166-176 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Futagami S, Miyake K et al.: "Inhibition of H.pylori-induced cox2 aggravates NSAID-caused gastric damage in Mongolian gerbils"Aliment Pharmacol Ther. 16(4). 847-855 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Miyake K, Tsukui T et al.: "Effect of acid suppression therapy on development of gastric erosions after cure of Helicobacter pylori infection"Aliment Pharmacol Ther. 16(supple 1.2). 1-7 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Miyake K, Tsukui T: "Irritant-induced cox 2 is involved in the defense mechanism of the gastric mucosa in mice."J Gastroenterol. 37(3). 164-171 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 三宅一昌, 坂本長逸: "Annual Review 消火器2002 新しい消化管治療薬"中外医学社. 6 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Miyake K, Tsukui T, Wada K, Tatsuguchi A, Futagami S, Hiratsuka T, Shinoki K, Iizumi T, Akamatsu T, Sakamoto C, Kabayashi M: "Irritant-induced cyclooxygenase-2 is involved in the defence mechanism of the gastric mucosa in mice."J Gastroenterol. 37(3). 164-171 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Miyake K, Tsukui T, Futagami S, Tatsuguchi A, Shinoki K, Hiratsuka T, Iizumi T, Nagata K, Shinji Y, Wada K, Yamada N, Kobayashi M, Sakamoto C: "Effect of acid suppression therapy on development of gastric erosions after cure of Helicobacter pylori infection."Aliment Pharmacol Ther. 16(supp1.2). 1-7 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Futagami S, Hiratsuka T, Wada K, Tatsuguchi A, Tsukui T, Miyake K, Akamatsu T, Hosone M, Sakamoto C, Kobayashi M: "Inhibition of Helicobacter pylori-induced cyclo-oxygenase-2 aggravates NSAID-caused gastric damage in Mongolian gerbils."Aliment Pharmacol Ther.. 16(4). 847-855 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Miura S, Tsukui T, Shinoki K, Takeyama H, Akamatsu T, Miyake K, Wada K, Mizokami Y, Kabayashi M, Matsuoka T, Sakamoto C: "Differential effects of cyclooxygenase-2 on vascular endothelial growth factor production in gastric fibroblasts and cancer cells."J Tokyo Med University. 60(3). 181-188 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Miyake K, Sakamoto C: "Prophylaxis against non-steroidal anti-inflammatory drug-associated ulcers and erosions"Nippon Rinsho. 60 Suppl 2. 577-582 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takeyama H, Tsukui T, Tatsuguchi A, Wada K, Miyake K, Shinoki K, Shinji Y, Iizumi T, Hiratsuka T, Gudies K, Futagami S, Miura S, Mizokami Y, Matsuoka T, Sakamoto C: "Non-steroidal anti-inflammatory drugs are not involved in ICAM-1 expression of endothelial cells but in that of gastric fibroblasts in vitro."J Tokyo Med University. 61(2). 166-176 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Futagami S, Hiratsuka T, Tatsuguchi A, Suzuki K, Kusunoki M, Shinji Y, Shinoki K, Iizumi T, Akamatsu T, Nishigaki H, Wada K, Miyake K, Gudis K, Tsukui T, Sakamoto C: "Monocyte chemoattractant protein 1 (MCP-1) released from Helicobacter pylori stimulated gastric epithelial cells induces cyclooxygenase 2 expression and activation in T cells."Gut.. 52(9). 1257-1264 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kazumasa Miyake, Taku Tsukui, Yoko Shinji, Kenji Suzuki, Kei Shinoki, Tetsuro Hiratsuka, Toshiaki Sugiura, Hitoshi Nishigaki, Seiji Futagami, Ken Wada, Katsuhiko Iwakini, Choitsu Sakamoto: "Teprenone, but not H2-receptor blocker or sucralfate, suppresses corpus helicobacter pylori colonization and gastritis in humans : teprenone inhibition of H. pylori-induced il-8 in MKN28 gastric epithelial cell lines"Helicobacter. 9(1)(in press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi